Author Description

The dramatic increase in the prevalence of diabetes, obesity, and metabolic syndrome worldwide has seriously threatened human health since its associated complications cause high morbidity and mortality. Among the complications, cardiovascular diseases are the predominant component. Although various controls for blood glucose and blood pressure are applied, patients with diabetes or obesity and associated metabolic syndromes are still at high risk of developing various cardiovascular diseases, nephropathy, retinopathy, neuropathy, skin disorders, and male infertility. Therefore, we need to understand the mechanisms underlying the pathogenesis of these complications in order to develop more effective therapies to prevent or slow down the progression of diabetic or metabolic syndrome complications.